Drug Information

Drug General Information
Drug ID
D04LTF
Former ID
DNC014898
Drug Name
TLN-4601
Drug Type
Small molecular drug
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 2 [522396]
Structure
Download
2D MOL

3D MOL
Formula
C28H34N2O4
Canonical SMILES
CC(=CCCC(=CCCC(=CCN1C2=CC(=CC(=C2NC3=C(C1=O)C=CC=C3O)O)<br />O)C)C)C
InChI
1S/C28H34N2O4/c1-18(2)8-5-9-19(3)10-6-11-20(4)14-15-30-23-16-21(31)17-25(33)27(23)29-26-22(28(30)34)12-7-13-24(26)32/h7-8,10,12-14,16-17,29,31-33H,5-6,9,11,15H2,1-4H3/b19-10+,20-14+
InChIKey
SALVHVNECODMJP-GNUCVDFRSA-N
PubChem Compound ID
9868980
PubChem Substance ID
14833926, 24160205, 45291244, 71825016, 79272066, 87550990, 103691118, 139292001, 163642567, 172919730, 198979381, 242082175
Target and Pathway
Target(s) Peripheral-type benzodiazepine receptor Target Info Modulator
KEGG Pathway Neuroactive ligand-receptor interaction
HTLV-I infection
References
Ref 522396ClinicalTrials.gov (NCT00730262) Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme. U.S. National Institutes of Health.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.